Clinical Trial Update: Sacubitril/Valsartan for CKD5 Stage Dialysis Patients [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update on sacubitril/valsartan in patients with CKD stage 5 on dialysis and heart failure has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease Stage
• Heart Failure

Drugs mentioned

• Sacubitril/Valsartan (sacubitril/valsartan)

Snippet

Sponsor: Ruijin Hospital | Conditions: CKD5 Stage Dialysis, Heart Failure | Phase 4 | Status: COMPLETED